Epi Biotech Co (XKRX:446440) Gross-Profit-to-Asset % : 0.00% (As of . 20)

View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Epi Biotech Co's annualized Gross Profit for the quarter that ended in . 20 was ₩ Mil. Epi Biotech Co's average Total Assets over the quarter that ended in . 20 was ₩ 0 Mil. Therefore, Epi Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Epi Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Epi Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Gross-Profit-to-Asset % Chart

Epi Biotech Co Annual Data

Trend

Gross-Profit-to-Asset %

Epi Biotech Co Semi-Annual Data

Gross-Profit-to-Asset %

Competitive Comparison of Epi Biotech Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Epi Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epi Biotech Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Epi Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Epi Biotech Co's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Epi Biotech Co Gross-Profit-to-Asset % Calculation

Epi Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: . 20 )	/	( (Total Assets (A: . 20 )	+	Total Assets (A: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Epi Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Epi Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Epi Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984

Website

http://www.epibiotech.com

Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines